Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930082

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930082

Biosensors Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 162 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of biosensors Market

The global biosensors market is witnessing strong growth due to rising demand for rapid, accurate, and minimally invasive diagnostic solutions across healthcare and non-healthcare applications. According to Fortune Business Insights, the biosensors market size was valued at USD 29.88 billion in 2025 and is projected to grow to USD 32.60 billion in 2026. With expanding adoption across clinical diagnostics, health monitoring, and point-of-care testing, the market is forecasted to reach USD 67.10 billion by 2034, exhibiting a CAGR of 9.44% during the 2026-2034 forecast period.

North America dominated the global biosensors market with a 44.53% share in 2025, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong adoption of wearable and point-of-care diagnostic technologies.

Market Overview

Biosensors are analytical devices that convert biological responses from enzymes, cells, or tissues into measurable electrical signals. These devices are widely used across medical diagnostics, agriculture, environmental monitoring, food safety, and biomedical research. In healthcare, biosensors enable early disease detection, continuous monitoring, and pain-free diagnostics, making them essential tools in modern clinical practice.

The increasing global burden of diabetes, cardiovascular diseases, and infectious disorders has significantly boosted demand for biosensor-based medical devices. Additionally, collaborations between semiconductor manufacturers and medical device companies are accelerating the development of highly precise biosensor platforms, further driving market growth.

Impact of COVID-19

The COVID-19 pandemic positively influenced the biosensors market in 2020 by accelerating the shift from centralized laboratory diagnostics to point-of-care and home-based testing. Increased adoption of self-testing and wearable biosensor-enabled devices continued during the post-pandemic period, supporting market growth in 2021 and beyond. Biosensors played a critical role in rapid diagnosis, disease surveillance, and remote patient monitoring.

Biosensors Market Trends

Rising Adoption of Biosensors for Diabetes Monitoring

One of the most prominent trends in the biosensors market is the growing deployment of devices for diabetes monitoring. Continuous glucose monitoring (CGM) systems using electrochemical biosensors are increasingly adopted across hospitals and homecare settings. These devices offer real-time monitoring, improved insulin management, and enhanced patient convenience.

According to Abbott, more than 3.0 million people worldwide were using the FreeStyle Libre CGM system in 2021, reflecting strong demand for biosensor-enabled diabetes solutions. Ongoing R&D efforts aimed at integrating insulin-monitoring biosensors with glucose sensors are expected to further strengthen adoption.

Market Growth Factors

Technological Advancements in Biosensors

Rapid advancements in nanomaterials, graphene-based sensors, fluorescence tagging, and fiber-optic technologies are significantly improving biosensor sensitivity, selectivity, and accuracy. These innovations are expanding biosensor applications across drug discovery, cancer diagnostics, and infectious disease testing.

For example, in January 2022, IDENTIFYSENSORS developed a graphene-based SARS-CoV-2 biosensor with approximately 96.0% sensitivity, highlighting the role of advanced materials in next-generation diagnostics.

Restraining Factors

Despite strong growth potential, the market faces challenges such as high production costs, limited sensor stability, and short device lifespan. Issues related to sensor degradation, drift, and frequent component replacement can restrict long-term adoption, particularly in resource-limited settings.

Segmentation Analysis

By Type

The market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, and others.

Electrochemical biosensors dominated the market with an 80.60% share in 2026, driven by widespread adoption of glucose monitoring devices. Optical biosensors are expected to grow at the fastest rate due to increasing demand for non-invasive diagnostics.

By Application

Based on application, the market includes clinical diagnostics, health monitoring, and others.

The clinical diagnostics segment held the largest share of 67.22% in 2026, supported by the rising number of point-of-care diagnostic tests worldwide.

By End User

By end user, the market is segmented into medical device companies, CDMOs, and others.

Medical device companies dominated the market with a 73.14% share in 2026, owing to strong product development initiatives and growing demand for biosensor-enabled healthcare devices.

Regional Insights

The North America biosensors market was valued at USD 13.30 billion in 2025 and increased to USD 14.47 billion in 2026, driven by continuous product launches and regulatory approvals.

Europe held a significant share due to strong healthcare research funding and biosensor R&D initiatives.

Asia Pacific is expected to record the highest growth rate, supported by rising diabetes prevalence and increasing adoption of point-of-care diagnostics.

Competitive Landscape

The biosensors market is dominated by key players such as Abbott, Medtronic, F. Hoffmann-La Roche Ltd., DuPont, Universal Biosensors, and Koninklijke Philips N.V. These companies focus on strategic collaborations, product launches, and technological innovation to strengthen their global presence.

Conclusion

In conclusion, the global biosensors market, valued at USD 29.88 billion in 2025, is projected to grow to USD 32.60 billion in 2026 and further reach USD 67.10 billion by 2034. Growth is driven by rising chronic disease prevalence, technological advancements, and expanding adoption of point-of-care and home-based diagnostic solutions.

Growth Rate CAGR of 9.44% from 2026-2034

Segmentation By Type

  • Electrochemical Biosensors
  • Optical Sensors
  • Piezoelectric Sensors
  • Others

By Application

  • Clinical Diagnostics
    • Glucose Monitoring
    • Infectious Disease Screening
    • Pregnancy & Fertility Testing
    • Others
  • Health Monitoring
    • Vital Signs Monitoring
    • Activity Tracking
  • Others

By End User

  • Medical Device Companies
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Others

By Region

  • North America (By Type, By Application, By End User and By Country)
    • U.S.
    • Canada
  • Europe (By Type, By Application, By End User and By Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, By Application, By End User and By Country/Sub-region)
    • Japan
    • China
    • India
    • Southeast Asia
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, By Application, By End User and By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, By Application, By End User and By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Product Code: FBI100146

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of R&D Expenditure, Key Players, 2025
  • 4.2. Overview: Technological Advancements in Biosensors
  • 4.3. Key Industry Developments - Partnerships, Mergers & Acquisitions
  • 4.4. New Product Launches
  • 4.5. Impact of COVID-19 on the Market

5. Global Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Electrochemical Biosensors
    • 5.1.2. Optical Biosensors
    • 5.1.3. Piezoelectric Biosensors
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Clinical Diagnostics
      • 5.2.1.1. Glucose Monitoring
      • 5.2.1.2. Infectious Disease Screening
      • 5.2.1.3. Pregnancy & Fertility Testing
      • 5.2.1.4. Others
    • 5.2.2. Health Monitoring
      • 5.2.2.1. Vital Signs Monitoring
      • 5.2.2.2. Activity Tracking
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Medical Device Companies
    • 5.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Electrochemical Biosensors
    • 6.1.2. Optical Biosensors
    • 6.1.3. Piezoelectric Biosensors
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Clinical Diagnostics
      • 6.2.1.1. Glucose Monitoring
      • 6.2.1.2. Infectious Disease Screening
      • 6.2.1.3. Pregnancy & Fertility Testing
      • 6.2.1.4. Others
    • 6.2.2. Health Monitoring
      • 6.2.2.1. Vital Signs Monitoring
      • 6.2.2.2. Activity Tracking
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Medical Device Companies
    • 6.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Electrochemical Biosensors
    • 7.1.2. Optical Biosensors
    • 7.1.3. Piezoelectric Biosensors
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Clinical Diagnostics
      • 7.2.1.1. Glucose Monitoring
      • 7.2.1.2. Infectious Disease Screening
      • 7.2.1.3. Pregnancy & Fertility Testing
      • 7.2.1.4. Others
    • 7.2.2. Health Monitoring
      • 7.2.2.1. Vital Signs Monitoring
      • 7.2.2.2. Activity Tracking
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Medical Device Companies
    • 7.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Rest of Europe

8. Asia pacific Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Electrochemical Biosensors
    • 8.1.2. Optical Biosensors
    • 8.1.3. Piezoelectric Biosensors
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Clinical Diagnostics
      • 8.2.1.1. Glucose Monitoring
      • 8.2.1.2. Infectious Disease Screening
      • 8.2.1.3. Pregnancy & Fertility Testing
      • 8.2.1.4. Others
    • 8.2.2. Health Monitoring
      • 8.2.2.1. Vital Signs Monitoring
      • 8.2.2.2. Activity Tracking
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Medical Device Companies
    • 8.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country/Sub-region
    • 8.4.1. Japan
    • 8.4.2. Australia
    • 8.4.3. China
    • 8.4.4. India
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Electrochemical Biosensors
    • 9.1.2. Optical Biosensors
    • 9.1.3. Piezoelectric Biosensors
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Clinical Diagnostics
      • 9.2.1.1. Glucose Monitoring
      • 9.2.1.2. Infectious Disease Screening
      • 9.2.1.3. Pregnancy & Fertility Testing
      • 9.2.1.4. Others
    • 9.2.2. Health Monitoring
      • 9.2.2.1. Vital Signs Monitoring
      • 9.2.2.2. Activity Tracking
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Medical Device Companies
    • 9.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Biosensors Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Electrochemical Biosensors
    • 10.1.2. Optical Biosensors
    • 10.1.3. Piezoelectric Biosensors
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Clinical Diagnostics
      • 10.2.1.1. Glucose Monitoring
      • 10.2.1.2. Infectious Disease Screening
      • 10.2.1.3. Pregnancy & Fertility Testing
      • 10.2.1.4. Others
    • 10.2.2. Health Monitoring
      • 10.2.2.1. Vital Signs Monitoring
      • 10.2.2.2. Activity Tracking
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Medical Device Companies
    • 10.3.2. Contract Development and Manufacturing Organizations (CDMOs)
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Abbott
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Medtronic
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Universal Biosensors
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. DuPont
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Biosensors International Group, Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Bio-Rad Laboratories Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Koninklijke Philips N.V.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. LifeScan IP Holdings, LLC
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Molecular Devices, LLC.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)
Product Code: FBI100146

List of Tables

  • Table 1: Global Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 4: Global Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 5: Global Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Biosensors Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 8: North America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 10: North America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 11: North America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Biosensors Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 14: Europe Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Europe Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 16: Europe Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 17: Europe Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 22: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 23: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 26: Latin America Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Latin America Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 28: Latin America Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 29: Latin America Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 33: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Clinical Diagnostics, 2021-2034
  • Table 34: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by Health Monitoring, 2021-2034
  • Table 35: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Biosensors Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Biosensors Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Biosensors Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Biosensors Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Biosensors Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Biosensors Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Biosensors Market Value Share (%), by Type, 2025
  • Figure 8: North America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Biosensors Market Value Share (%), by Application, 2025
  • Figure 10: North America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 12: North America Biosensors Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Biosensors Market Value Share (%), By Country, 2025
  • Figure 14: Europe Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Biosensors Market Value Share (%), by Type, 2025
  • Figure 16: Europe Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Biosensors Market Value Share (%), by Application, 2025
  • Figure 18: Europe Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Biosensors Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Biosensors Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Biosensors Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Biosensors Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Biosensors Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Biosensors Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Biosensors Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Biosensors Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Biosensors Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Biosensors Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Biosensors Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Biosensors Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Biosensors Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Biosensors Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Biosensors Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Biosensors Market Share (%), By Company, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!